米国企業
BIO KEY INTERNATIONAL INC

BIO KEY INTERNATIONAL INCBKYI

時価総額

$1661.5万

PER

	2011年 12月31日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
Cash and cash equivalents	43,437	83,989	2	843,632	4,321,078	1,061,307	288,721	323,943	79,013	16,993,096	8	3
Accounts receivable, net	587,346	604,784	284,025	625,341	3,391,405	1,563,246	2,875,946	1,574,032	126,000	548,049	970,626	2
Due from factor	-	189,904	2,449	76,657	37,421	53,638	109,865	56,682	110,941	60,453	49,500	49,500
Note receivable, net of allowance	-	-	-	-	-	-	-	-	-	295,000	82,000	-
Inventory, net of reserve	8,238	4,186	9,376	11,825	348,645	465,428	946,847	998,829	429,119	330,947	4,940,660	4
Prepaid expenses and other	58,920	25,088	73,482	236,429	97,203	206,677	152,654	150,811	108,397	201,507	216,041	342,706
Total current assets	697,941	907,951	2	2	13,195,752	4,910,296	7,014,033	4,229,297	1,366,291	18,941,873	14,012,873	9
Resalable software license rights	-	-	-	-	7,000,000	10,598,411	7,933,808	6,790,610	73,802	58,882	48,752	-
Investment – debt security, net	-	-	-	-	-	-	-	-	-	-	452,821	-
Equipment and leasehold improvements, net	52,870	24,267	125,062	103,509	63,877	67,814	181,165	148,608	95,509	81,793	69,168	107,413
Capitalized contract costs, net	-	-	-	-	-	-	-	319,199	231,519	165,315	249,012	283,069
Deposits and other assets	8,712	8,712	8,712	8,712	8,712	8,712	8,712	8,712	8,712	8,712	8,712	8,712
Note receivable, net of allowance	-	-	-	-	-	-	-	-	-	-	113,000	-
Operating lease right-of-use assets	-	-	-	-	-	-	-	-	566,479	487,325	254,100	197,355
Intangible assets, net	207,180	195,911	174,950	161,344	147,738	134,132	181,104	195,906	154,386	1,514,146	1,298,077	2
Goodwill	-	-	-	-	-	-	-	-	-	1,262,526	1,262,526	-
Total non-current assets	268,762	228,890	308,724	273,565	7,220,327	12,379,069	9,064,789	7,463,035	1,130,407	3,578,699	3,756,168	2
TOTAL ASSETS	966,703	1	3	2	20,416,079	17,289,365	16,078,822	11,692,332	2,496,698	22,520,572	17,769,041	11
Accounts payable	687,441	931,276	540,912	347,311	1,158,555	466,842	499,230	481,269	919,294	244,158	427,772	1
Accrued liabilities	675,833	593,599	338,321	488,617	626,918	335,323	688,023	548,232	686,885	508,487	828,997	1
Convertible note payable, net of debt discount	-	-	-	-	-	-	-	-	-	232,000	-	3
Government loan – BBVA Bank, current portion	-	-	-	-	-	-	-	-	-	-	-	120,000
Deferred revenue - current	-	-	-	-	-	-	-	196,609	359,212	657,349	565,355	462,418
Operating lease liabilities, current portion	-	-	-	-	-	-	-	-	170,560	234,309	177,188	159,665
Total current liabilities	2	2	1	1	2,266,162	1,836,477	2,325,527	1,226,110	4,391,405	1,876,303	1,999,312	5
Deferred revenue, net of current portion	-	-	-	-	-	-	-	-	-	44,987	67,300	52,134
Deferred tax liability	-	-	-	-	-	-	-	-	-	-	-	170,281
Government loan – BBVA Bank, net of current portion	-	-	-	-	-	-	-	-	-	-	-	326,767
Operating lease liabilities, net of current portion	-	-	-	-	-	-	-	-	390,466	264,163	86,974	37,829
Total non-current liabilities	1,000	-	243,077	-	-	-	-	-	390,466	309,150	154,274	587,011
TOTAL LIABILITIES	2	2	2	1	2,266,162	1,836,477	2,325,527	1,226,110	4,781,871	2,185,453	2,153,586	6
Common stock — authorized, 170,000,000 shares; issued and outstanding; 9,190,504 and 7,853,759 of $.0001 par value at December 31, 2022 and December 31, 2021, respectively	7,815	7,815	11,584	6,600	6,610	609	769	1,398	1,441	782	786	919
Additional paid-in capital	51	51	56	58	76,754,737	78,253,413	80,829,001	85,599,140	87,436,402	119,844,026	120,190,139	122
Accumulated other comprehensive loss	-	-	-	-	-	-	-	-	-	-	-	-242,602
Accumulated deficit	-52,291,688	-52,288,421	-54,870,572	-56,754,144	-58,611,450	-62,801,154	-67,076,492	-75,134,316	-89,723,016	-99,509,689	-104,575,470	-116,485,373
TOTAL STOCKHOLDERS’ EQUITY	-1,271,091	-1,217,982	1	759,061	18,149,917	15,452,888	13,753,295	10,466,222	-2,285,173	20,335,119	15,615,455	5
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	966,703	1	3	2	20,416,079	17,289,365	16,078,822	11,692,332	2,496,698	22,520,572	17,769,041	11